Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000554263 | SCV000626129 | pathogenic | Multiple congenital exostosis | 2023-09-09 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 456062). This variant is also known as 2077-2082insC and 2077ins1. This premature translational stop signal has been observed in individuals with chondrosarcoma (PMID: 8981950, 9521425, 19810120, 25468659, 25541963). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser478Leufs*43) in the EXT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT1 are known to be pathogenic (PMID: 10679937, 11391482, 19810120). |
Gene |
RCV000627404 | SCV000748398 | pathogenic | not provided | 2020-10-30 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 18373409, 8981950, 17041877, 10679937, 25468659, 19810120, 9521425, 21499719, 25541963, 30334991, 31400121) |
OMIM | RCV002267737 | SCV000022760 | pathogenic | Chondrosarcoma | 1997-01-01 | no assertion criteria provided | literature only |